Swecure Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

Swecure General Information

Description

Developer of bacterial therapeutics treatments designed to treat immunoregulatory disorders, such as allergy and IBD. The company's treatments are based on extensive studies on the correlations between certain bacteria in the microbiome and disease development later in life, enabling people with immunoregulatory disorders to improve quality of life.

Contact Information

Website
www.swecure.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Stureplan 15
  • 111 45 Stockholm
  • Sweden
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Stureplan 15
  • 111 45 Stockholm
  • Sweden

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Swecure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jan-2020 Completed Out of Business
2. Early Stage VC Completed Startup
1. Accelerator/Incubator Completed Startup
To view Swecure’s complete valuation and funding history, request access »

Swecure Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Swecure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180200358-A1 Reducing the risk of developing of atopic dermatitis by use of superantigen Inactive 14-Jul-2015
US-20170333551-A1 Use of superantigens for improving mucosal allergen specific immunotherapy in human beings Inactive 14-Oct-2014
US-20180028579-A1 Use of collinsella for treatment of inflammatory bowel disease Inactive 12-Sep-2014
EP-2995314-A1 Use of collinsella for treatment of inflammatory bowel disease Inactive 12-Sep-2014
CA-2574093-A1 Prevention of allergy in children Active 16-Jul-2004 A61K39/085
To view Swecure’s complete patent history, request access »

Swecure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Swecure Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hargay Asset Manager Minority
To view Swecure’s complete investors history, request access »

Ready to get started?

Request a free trial

Swecure FAQs

  • When was Swecure founded?

    Swecure was founded in 2013.

  • Where is Swecure headquartered?

    Swecure is headquartered in Stockholm, Sweden.

  • What is the size of Swecure?

    Swecure has 5 total employees.

  • What industry is Swecure in?

    Swecure’s primary industry is Biotechnology.

  • Is Swecure a private or public company?

    Swecure is a Private company.

  • What is Swecure’s current revenue?

    The current revenue for Swecure is .

  • Who are Swecure’s investors?

    Hargay has invested in Swecure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »